• Earnings Per Share (EPS) of $0.78, beating the estimated $0.71 and marking a significant year-over-year improvement.
• Revenue reached approximately $300.4 million, surpassing estimates and indicating a 21% increase from the previous year.
• Despite a decrease in net income, non-GAAP net income rose by 33%, showcasing strong adjusted financial performance.

HealthEquity, Inc. (NASDAQ:HQY) is a prominent player in the Zacks Medical Services industry, specializing in providing services related to Health Savings Accounts (HSAs) and Consumer-Directed Benefits (CDBs). The company has consistently demonstrated strong financial performance, as evidenced by its recent earnings report for the third quarter ending October 31, 2024.

On December 9, 2024, HealthEquity reported earnings per share (EPS) of $0.78, surpassing the estimated $0.71. This represents a significant improvement from the $0.60 per share reported in the same quarter last year, as highlighted by Zacks. The earnings surprise for this quarter stands at 9.86%, showcasing the company's ability to exceed market expectations consistently.

In addition to strong earnings, HealthEquity achieved a revenue of approximately $300.4 million, exceeding the estimated $290.1 million. This marks a 21% increase from the $249.2 million reported in the same quarter of the previous fiscal year. The company has consistently surpassed consensus revenue estimates in the last four quarters, reflecting its robust growth trajectory.

Despite the impressive revenue growth, HealthEquity's net income decreased to $5.7 million from $14.7 million in Q3 FY24. However, the non-GAAP net income rose by 33% to $69.4 million, up from $52.2 million in the previous year. This indicates that while the company's traditional net income faced challenges, its adjusted financial performance remains strong.

HealthEquity's financial metrics further highlight its market position. The company has a price-to-earnings (P/E) ratio of approximately 91.07, indicating investor confidence in its future earnings potential. Its low debt-to-equity ratio of 0.03 suggests a conservative approach to debt, while a current ratio of 3.20 underscores its strong liquidity position.